Document is current
Any future updates will be listed below
-
Authors
Póti, Ádám Levente https://orcid.org/0000-0001-8811-0586
Bálint, Dániel https://orcid.org/0009-0001-7433-6063
Alexa, Anita https://orcid.org/0000-0002-5740-7835
Sok, Péter https://orcid.org/0000-0001-8963-8163
Ozsváth, Kristóf
Albert, Krisztián https://orcid.org/0009-0004-0516-604X
Turczel, Gábor https://orcid.org/0000-0002-6753-6796
Magyari, Sarolt https://orcid.org/0000-0003-4573-0915
Ember, Orsolya https://orcid.org/0009-0007-1346-9499
Papp, Kinga
Király, Sándor Balázs
Imre, Tímea
Németh, Krisztina
Kurtán, Tibor https://orcid.org/0000-0002-8831-8499
Gógl, Gergő
Varga, Szilárd
Soós, Tibor https://orcid.org/0000-0002-2872-4313
Reményi, Attila https://orcid.org/0000-0002-8345-1311
- License Information
-
More Information
Article History
Received: 22 August 2023
Accepted: 22 August 2024
First Online: 4 October 2024
Change Date: 28 October 2024
Change Type: Update
Change Details: In this article, compounds 34S and 34R in Table 4 did not display properly. The original article has been corrected.
Competing interests
: A.R., T.S., Á.L.P., D.B., A.A., P.S., K.A., O.E., T.I., and S.V. are inventors in a patent application pending approval (PCT/HU2023/050079) on the use of cyclic designer scaffolds for the covalent targeting of proteins via Michael addition. The remaining authors declare no competing interests.
